According to a new report Europe Cancer Registry Software Market, published by KBV Research, the Europe Cancer Registry Software Market would witness market growth of 9.85% CAGR during the forecast period (2019-2025).
The Germany market is one of the major regions in the Europe IT & Telecom Cancer Registry Software Market by Country in 2018, growing at a CAGR of 16.2 % during the forecast period. The UK market is anticipated to grow at a CAGR of 16.7% during (2019 - 2025). Additionally, The France market would witness a CAGR of 18.4% during (2019 - 2025).
The On-premise Cancer Registry Software Market dominated the Spain Cancer Registry Software Market by Deployment Model in 2018, growing at a CAGR of 10.6 % during the forecast period. The Cloud-based Cancer Registry Software Market is anticipated to grow at a CAGR of 11% during (2019 - 2025).
The Commercial Cancer Registry Software Market dominated the Italy Cancer Registry Software Market by Component in 2018, thereby, achieving a market value of $757.2 Thousands by 2025. The Public Cancer Registry Software Market would witness a CAGR of 10.2% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/europe-cancer-registry-software-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.
By Type
By Deployment Type
By Component
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
